Works from 2020
Delayed recurrence of chromophobe renal cell carcinoma presenting as metastatic duodenal ulcer, Nikita Jain, Anchit Bharat, Dipesh Ludhwani, et al. (Article)
The utility of extracorporeal membrane oxygenation in patients with hematologic malignancies: a literature review, Praveena Tathineni, Mauna Pandya, and Bassem Chaar (Article)
Phase II trial of carfilzomib plus irinotecan in patients with small-cell lung cancer who have progressed on prior platinum-based chemotherapy, Susanne M Arnold, Kari Chansky, Maria Q Baggstrom, et al. (Article)
Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect® MDS/AML Disease Registry, Daniel A. Pollyea, Tracy I. George, Michael A. Thompson, et al. (Article)
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study, Nicole M Kuderer, Toni K Choueiri, Dimpy P Shah, et al. (Article)
Management of hereditary breast cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline, Nadine M Tung, Judy C Boughey, Lori J Pierce, et al. (Article)
Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19), Jeremy L Warner, Sam Rubinstein, and Michael A. Thompson (Abstract)
Uncommon presentations of multiple myeloma, Praveena Tathineni, Ivan Cancarevic, and Bilal Haider Malik (Article)
HealthTree Patient Portal mediated myeloma patient-reported vaccination and antibiotic use, Michael A. Thompson, Jenny Ahlstrom, and Nathan W. Sweeney (Abstract)
Medicare compared with private insurance for the treatment of cancer, Phillip Martinez-Knouse, Christie Hancock, Edward Nabrinsky, et al. (Abstract)
Molecular alterations with hyperprogression in lung cancer patients treated with immune checkpoint inhibitors in a large health system, Eyob Tadesse, Kayla Heslin, Mohamed Hendawi, et al. (Abstract)
Multiple myeloma (MM) vaccination (influenza, FV and pneumococcal, PV) rates worldwide and impact on infection, hospitalization, and death, Michael A. Thompson, Caitlin Costello, and et al (Abstract)
REPOCH compared with RCHOP for the treatment of diffuse large B-cell lymphoma of activated B-cell type, Phillip Martinez-Knouse, Edward Nabrinsky, Anjana Chandran, et al. (Abstract)
Concordant genomic vulnerabilities of patient-derived cell line and matched xenograft-derived cell line through whole exome sequencing in breast-brain metastatic cancer, Jun Yin, Aspen T. Duffin, Kate Dennert, et al. (Article)
Gynecologic cancer patients’ interests in music therapy, Stephanie Veit, Jessica J F Kram, Kayla Heslin, et al. (Article)
Oncologic outcomes of robotic compared to open pancreatic surgery: A National Cancer Database participant user file study, Geoffrey Bellini, Maharaj Singh, James Weese, et al. (Poster)
Oncology precision medicine for hepatobiliary and pancreatic cancer: Insights and updates from a large community health system, Geoffrey Bellini, Nicholas Sich, Jennifer Godden, et al. (Poster)
P53 level and MGMT promoter methylation are playing a role in Zika virus replication in glioblastoma, Sam D. Zwernik, Beau Adams, Jun Yin, et al. (Article)
Predictors of lymphovascular invasion among female patients diagnosed with breast cancer, Maharaj Singh, Santhi Konduri, George C. Bobustuc, et al. (Poster)
Zika virus targets stem cell markers and modulates antiviral responses in glioblastoma cancer stem cells, Beau Adams, Sam D. Zwernik, Daniel Raymond, et al. (Article)
Can Magnetic Resonance Imaging Predict Pathologic Findings for Endometrioid Endometrial Cancer?, Elizabeth L. Dickson Michelson, Jessica J. F. Kram, Kayla Heslin, David Baugh, Vikram Bamra, Jiahao Hu, Abhishek Shukla, and Scott A. Kamelle (Brief Report)
Coronavirus disease 2019 (COVID-19) in cancer patients, Ivan Cancarevic, Praveena Tathineni, and Bilal Haider Malik (Article)
Local recurrence following resection of intermediate-high risk nonmetastatic renal ell arcinoma: an anatomical lassification and analysis of the ASSURE (ECOG-ACRIN E2805) adjuvant trial, Ziho Lee, Opeyemi A Jegede, Naomi B Haas, et al. (Article)
Phase II trial of neoadjuvant systemic chemotherapy followed by extirpative surgery in patients with high grade upper tract urothelial carcinoma, Vitaly Margulis, Maneka Puligandla, Edouard J Trabulsi, et al. (Article)
Reply by authors, Vitaly Margulis, Maneka Puligandla, Edouard J Trabulsi, et al. (Response or Comment)
Uterine cervical sarcoma with a novel RET-SPECC1L fusion in an adult: A case which expands the homology between RET-rearranged and NTRK-rearranged tumors, Paul S Weisman, Morgan Altinok, Erica V Carballo, et al. (Article)
Metastatic melanoma mimicking right atrial myxoma: Multimodality imaging, Mahmoud Ali, Amina Adil, Marc Atzenhoefer, et al. (Abstract)
Clinical outcomes in early breast cancer with a high 21-gene recurrence score of 26 to 100 assigned to adjuvant chemotherapy plus endocrine therapy: A secondary analysis of the TAILORx randomized clinical trial, Joseph A Sparano, Robert J Gray, Della F Makower, et al. (Article)
Transplant referral patterns for patients (pts) with newly diagnosed (ND) higher-risk (HR) myelodysplastic dyndromes (MDS), and European leukemianet (ELN) 2010 intermediate-tisk (IR) or adverse-risk (AR) acute myeloid leukemia (AML) in the Connect® MDS/AML registry, Benjamin Tomlinson, Marcos de Lima, Christopher R. Cogle, et al. (Abstract)
WEE1 inhibitor, AZD1775, overcomes trastuzumab resistance by targeting cancer stem-like properties in HER2-positive breast cancer, Andrea Sand, Mitchel Piacsek, Deborah Donohoe, et al. (Article)
Splicing profile by capture RNA-seq identifies pathogenic germline variants in tumor suppressor genes, Tyler Landrith, Bing Li, Ashley A Cass, et al. (Article)
Long-term survival in a patient with butterfly glioblastoma: A case report, Megan Finneran, Dario A Marotta, Dana Altenburger, et al. (Case Report)
Comparing survival outcomes for neoadjuvant therapy versus adjuvant therapy in the management of stage 1 pancreatic adenocarcinoma: A National Cancer Database study, Samit K. Datta, Geoffrey Bellini, Maharaj Singh, et al. (Abstract)
Advancing patient age is associated with worse outcomes in low- and intermediate-grade primary chondrosarcoma of the pelvis, Matthew T Houdek, Brent G. Witten, Mario Hevesi, et al. (Article)
Improved surgical margins with neoadjuvant versus adjuvant chemotherapy in clinical stage I resectable pancreatic adenocarcinoma: A National Cancer Database study, Geoffrey Bellini, Samit K. Datta, Nicholas Sich, et al. (Article)
Oncology precision medicine for hepatobiliary and pancreatic cancer: Insights and updates upon an institutional review, Geoffrey Bellini, Nicholas Sich, Jennifer Godden, et al. (Abstract)
MammaPrint guides treatment decisions in breast cancer: results of the IMPACt trial., Hatem Soliman, Varsha Shah, Gordan Srkalovic, et al. (Article)
Cell death pathways in lymphoid malignancies, Luke Fletcher, Edward Nabrinsky, Tingting Liu, et al. (Article)
The use of sublaminar wiring in the sub-axial cervical spine as an adjuvant to lateral mass and pedicle screw fixation in a patient with metastatic carcinoma of the upper thoracic spine, Calvin C Whaley, Michael Young, and Jason M Seibly (Article)
Myeloid sarcomas causing unilateral cranial nerve palsies in a patient with relapsed acute myeloblastic leukemia, A Mendez-Hernandez, X A Andrade, S Upadhyay, et al. (Article)
Crowdsourcing a crisis response for COVID-19 in oncology, Aakash Desai, Jeremy Warner, Nicole Kuderer, et al. (Article)
MET receptor in oncology: from biomarker to therapeutic target, Raeva Malik, Isa Mambetsariev, Jeremy Fricke, et al. (Article)
Primary epithelioid angiosarcoma of the uterus: a rare tumor with very aggressive behavior, Nasma K Majeed, Brian Adley, Grace Guzman, et al. (Article)
Works from 2019
Sexual quality of life after the treatment of gynecologic cancer: what women want, J L Hubbs, Elizabeth L. Dickson Michelson, R I Vogel, et al. (Article)
Ibrutinib and rituximab provides superior clinical outcome compared to FCR in younger patients with chronic lymphocytic leukemia (CLL): Extended follow-up from the E1912 trial, Tait D Shanafelt, Victoria Wang, Neil E Kay, et al. (Article)
TP53 status as a determinant of pro- versus anti-tumorigenic effects of estrogen receptor-beta in breast cancer, Utpal K Mukhopadhyay, Chetan C Oturkar, Christina Adams, et al. (Article)
Squamous cell carcinoma of the tongue with metastasis to myocardium: Report of a case and literature review, Ali Shafiq, Fatima Samad, Eric Roberts, et al. (Article)
American Urological Association non-muscle invasive bladder cancer risk model validation: should patient age be added to the risk model?, Kourosh Ravvaz, John A Weissert, and Tracy M Downs (Article)
ASCO Research Community Forum: Impact on clinical research, David M. Waterhouse, Nicholas J. Robert, Edward S. Kim, et al. (Abstract)
Ibrutinib-rituximab or chemoimmunotherapy for chronic lymphocytic leukemia, Tait D Shanafelt, Xin V Wang, Neil E Kay, et al. (Article)
Organizing online health content: developing hashtag collections for healthier internet-based people and communities, Matthew S Katz, Patricia F Anderson, Michael A. Thompson, et al. (Article)
Oncology precision medicine for hepatobiliary and pancreatic cancer: An institutional review, Geoffrey Bellini, Jennifer Godden, James Weese, et al. (Abstract)
Physiological and psychosocial effects of a highly structured exercise program on breast cancer survivorship, Judy A. Tjoe, Linda B Piacentine, Jun Yin, et al. (Abstract)
Reduced blood product utilization via implementation of an anemia clinic and consult service in a large health system hospital: Focus on cardiovascular patients, Reid Christian Bowers, Sandra Tomany Korman, Michael A. Thompson, et al. (Abstract)
Use of treatment pathways reduce cost and decrease ED utilization and unplanned hospital admissions in patients (pts) with stage II breast cancer, James Weese, Corey J. Shamah, Federico A. Sanchez, et al. (Abstract)
Variability in sentinel lymph node biopsy retrieval for breast cancer at Aurora Health Care, Aaron H. Chevinsky, Judy A. Tjoe, William L. Owens, et al. (Abstract)
Epidemiology of male breast cancer, Santhi Konduri, Maharaj Singh, George C. Bobustuc, et al. (Abstract)
Evaluation of Sox2 expression in glioblastoma stem cells during zika virus infection, Beau Adams, Sam D. Zwernik, Amin Kassam, et al. (Abstract)
No-cost next generation sequencing of advanced cancer patients within the Strata Precision Oncology Network supports clinical trial enrollment, Marc Ryan Matrana, Scott A. Tomlins, Kat Kwiatkowski, et al. (Abstract)
Lymphedema precautions: When are they required? A literature review, Michelle Grube (Poster)
p16 as a biomarker to distinguish atypical ductal hyperplasia from ductal carcinoma in situ and to predict breast cancer progression, Judy A. Tjoe, Brittany S. Last, and Jun Yin (Abstract)
INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myeloma, Caitlin Costello, Faith E Davies, Gordon Cook, et al. (Article)
Mo1412 – Oncologic outcomes of robotic compared to open pancreatic surgery: A national cancer database participant user file study, Geoffrey Bellini, Maharaj Singh, James Weese, et al. (Abstract)
Rare myeloid sarcoma with KMT2A (MLL)-ELL fusion presenting as a vaginal wall mass, Haiyan Bao, Juehua Gao, Yi-Hua Chen, et al. (Article)
C-reactive protein in HPV-positive and HPV-negative oropharyngeal cancer, Stephanie Johnson-Obaseki, Lisa Caulley, Martin Corsten, et al. (Article)
Determining value of a precision medicine program in a vertically integrated healthcare system, James Weese, Michael A. Thompson, and Jennifer Godden (Oral/Podium Presentation)
Racial disparity in gastrointestinal cancer: insight from national cancer database, Maharaj Singh, Samit K. Datta, Wesley Papenfuss, et al. (Abstract)
Survival outcomes between surgery with adjuvant therapy compared to neoadjuvant therapy with surgery in stage I pancreatic adenocarcinoma: Results from a large national cancer database, Samit K. Datta, Geoffrey Belini, Maharaj Singh, et al. (Abstract)
Survival outcomes comparable between endoscopic resection and surgical resection, Samit K. Datta, Geoffrey Belini, Maharaj Singh, et al. (Abstract)
Coordinating an Oncology Precision Medicine Clinic Within an Integrated Health System: Lessons Learned in Year One, Michael A. Thompson, Jennifer J. Godden, Deborah Wham, Antony Ruggeri, Michael P. Mullane, Amanda Wilson, Shamsuddin Virani, Scott M. Weissman, Brenda Ramczyk, Pamela Vanderwall, and James L. Weese (Review)
Concurrent versus non-concurrent immune checkpoint inhibition with stereotactic radiosurgery for metastatic brain disease: a systematic review and meta-analysis, Victor M Lu, Anshit Goyal, Richard A. Rovin, et al. (Article)
Works from 2018
Social media and clinical trials: The pros and cons gain context when the patient is at the center, Michael A. Thompson and Ruth M O'Regan (Article)
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) on social media: #BPDCN-increasing exposure over two years since inception of a disease-specific twitter community, Naveen Pemmaraju, Audun Utengen, Vikas Gupta, et al. (Article)
Follicular dendritic cell sarcoma with indolent T-lymphoblastic proliferation is associated with paraneoplastic autoimmune multiorgan syndrome, Matthew Walters, Mark R Pittelkow, Robert P Hasserjian, et al. (Article)
Promoting team-based exercise among African American breast cancer survivors, Linda B Piacentine, Karen M Robinson, Leslie J. Waltke, et al. (Article)
Non-human papillomavirus cervical mucinous adenocarcinoma in a phenotypic male with congenital adrenal hyperplasia, Jennifer Heim, Elizabeth L. Dickson, Melissa Aa Geller, et al. (Article)
Precision medicine/genetics: Advocate Aurora Health cancer screening updates for the primary care clinician, Michael A. Thompson and Michael P. Mullane (Oral/Podium Presentation)
Can we improve nonmuscle invasive bladder cancer guideline adherence with smarter risk stratification?, Tracy M Downs, John Weissert, and Kourosh Ravvaz (Editorial)
A global treatment standard in multiple myeloma (MM) remains elusive despite advances in care over 15 years: first results from INSIGHT MM, the largest global prospective, observational MM study, Caitlin L. Costello, Mario Boccadoro, Michael A. Thompson, et al. (Abstract)
Differential regulation of human monocytes and NK cells by antibody-opsonized tumors, Jun Yin, Alex J. Albers, Thomas S. Smith, et al. (Article)
Racial Disparity Among Women Diagnosed With Invasive Breast Cancer in a Large Integrated Health System, Maharaj Singh, Santhi D. Konduri, George C. Bobustuc, Amin B. Kassam, and Richard A. Rovin (Original Research)
Decreased trend in hospital mortality from pancreatic cancer despite increase in number of hospital admissions, Sanjay Bhandari, Mubeen Khan Mohammed Abdul, Will Hollabaugh, et al. (Article)
MGMT inhibition in ER positive breast cancer leads to CDC2, TOP2A, AURKB, CDC20, KIF20A, Cyclin A2, Cyclin B2, Cyclin D1, ERα and survivin inhibition and enhances response to temozolomide, George C. Bobustuc, Amin B. Kassam, Richard Rovin, et al. (Article)
The survival effect of repeat surgery at glioblastoma recurrence and its trend: a systematic review and meta-analysis, Victor M Lu, Toni R Jue, Kerrie L McDonald, et al. (Article)
One pulmonary lesion, 2 synchronous malignancies, Masooma Aqeel, Nevin Uysal-Biggs, Timothy S Fenske, et al. (Article)
Implementing precision medicine programs and clinical trials in the community-based oncology practice: barriers and best practices, J L. Ersek, L J. Black, Michael A. Thompson, et al. (Book Chapter)
Drug targeting: repurposing FDA therapeutic drugs to treat triple-negative breast cancer, Paul J. Mintz, Jerald Smith, Andrea Sand, et al. (Abstract)
Initiation of a Hyperthermic Intraperitoneal Chemotherapy (HIPEC) program at Aurora Health Care, Aaron H. Chevinsky, Wesley Papenfuss, Federico A. Sanchez, et al. (Abstract)
Identification, prioritization, and treatment of mutations identified by next-generation sequencing, Aaron S Mansfield, Ben Ho Park, and Michael P. Mullane (Book Chapter)
Implementing precision medicine programs and clinical trials in the community-based oncology practice: barriers and best practices, Jennifer L Ersek, Lora J Black, Michael A. Thompson, et al. (Book Chapter)
Multidisciplinary management of oligometastatic soft tissue sarcoma, Juneko E Grilley-Olson, Nicholas P. Webber, David S. Demos, et al. (Book Chapter)
The effects of checkpoint blockade and a CD40 agonist on T-independent and T-dependent antibody responses in mice: implications for optimization of vaccination strategies in patients receiving immunotherapies, Karen Michel, Ashley Gehrand, Michael A. Thompson, et al. (Article)
The effects of checkpoint blockade and a CD40 agonist on T-independent and T-dependent antibody responses in mice: implications for optimization of vaccination strategies in patients receiving immunotherapies, Karen Michel, Ashley Gehrand, Michael A. Thompson, et al. (Article)
Drug-specific videos for patient chemotherapy education, James Weese, Kerry A. Twite, Marija Bjegovich-Weidman, et al. (Article)
RETRACTED: Sentinel lymph node mapping in endometrioid endometrial cancer: does it work in the real world? [22A], Olga Valieva, Danielle M. Greer, Jessica J. Kram, et al. (Abstract)
The Needs of Women Treated for Ovarian Cancer: Results From a #gyncsm Twitter Chat, Teresa Hagan Thomas, Karin Nauth-Shelley, Michael A. Thompson, Deanna J. Attai, Matthew S. Katz, David Graham, Dee Sparacio, Christina Lizaso, Audun Utengen, and Don S. Dizon (Original Research)
BRD4 inhibition Is synthetic lethal with PARP inhibitors through the induction of homologous recombination deficiency, Chaoyang Sun, Jun Yin, Yong Fang, et al. (Article)
Androgen deprivation therapy for prostate cancer and incident atrial fibrillation, Zuber S. Ali, Tadele Mengesha, Suhail Allaqaband, et al. (Poster)
Metastatic recurrent hepatocellular carcinoma post liver transplant with marked pretransplant elevation of alpha fetoprotein and no evidence of primary neoplasm, Shiva Kumar (Article)
Association of 70-gene signature assay findings with physicians' treatment guidance for patients with early breast cancer classified as intermediate risk by the 21-gene assay, Michaela Tsai, Shelly Lo, William Audeh, et al. (Article)